EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Invasive aspergillosis in surgical intensive care patients


Annales Francaises D'anesthesie et de Reanimation 12(4): 379-384
Invasive aspergillosis in surgical intensive care patients
Aspergillosis is a rare event in intensive care patients. Three cases of invasive aspergillosis due to Aspergillus fumigatus were diagnosed in a surgical critical care unit. Risk factors for aspergillosis were found in two liver transplanted patients. One of them had a primitive cutaneous aspergillosis, and the other, treatment difficulties due to the unavailability of an injectable preparation of itraconazole, a new triazole antifungal agent efficient against Aspergillus species. The third case occurred in a patient who had had surgery for gastric carcinoma with liver metastasis. The mycological examination of the air and workbench in the patients' rooms disclosed between 2 and 13 CFU cntdot mm-3 of different Aspergillus species. Plasma itraconazole concentrations were measured in one patient only. They were below the therapeutic range, probably because of intestinal disturbances. The oral administration of itraconazole capsules through gastro-intestinal feeding tubes results in a poor availability of the drug. Such a technique of administration should therefore be undertaken with larger doses than those commonly recommended. Moreover, itraconazole plasma concentrations should be monitored. The association with amphotericin B is recommended until normal intestinal absorption has been obtained.

(PDF same-day service: $19.90)

Accession: 002416595

PMID: 8273926

DOI: 10.1016/S0750-7658(05)80105-4



Related references

Invasive aspergillosis on a surgical intensive care unit. Mycoses 43 Suppl 2: 23-27, 2001

Invasive aspergillosis in a surgical intensive care unit. Mycoses 43(Suppl.2): 23-27, 2000

The clinical monitoring of invasive aspergillosis in surgical intensive care unit during 10 years. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 26(9): 634-638, 2016

Invasive aspergillosis in intensive care unit patients in Iran. Acta Medica 56(2): 52-56, 2014

The economic impact of invasive aspergillosis in intensive care unit patients. International Journal of Infectious Diseases 14(6): E536-E537, 2010

Posaconazole in intensive care patients I: invasive fungal infections in surgical intensive care and case presentation. Mycoses 51 Suppl 2: 52-57, 2008

Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients. Mycoses 54(5): 420-433, 2011

Outcome of intensive care patients requiring mechanical ventilation during invasive pulmonary aspergillosis. European Respiratory Journal 12(SUPPL 28): 120S, Sept, 1998

Clinical risk factors and bronchoscopic features of invasive aspergillosis in intensive care unit patients. Journal of Preventive Medicine and Hygiene 54(2): 80-82, 2014

Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home. Indoor Air 24(6): 652-661, 2016